SE8603135L - N-nikotinoylaminosyror - Google Patents

N-nikotinoylaminosyror

Info

Publication number
SE8603135L
SE8603135L SE8603135A SE8603135A SE8603135L SE 8603135 L SE8603135 L SE 8603135L SE 8603135 A SE8603135 A SE 8603135A SE 8603135 A SE8603135 A SE 8603135A SE 8603135 L SE8603135 L SE 8603135L
Authority
SE
Sweden
Prior art keywords
image
compounds
disorders
3cooh
nicotinoylamino
Prior art date
Application number
SE8603135A
Other languages
English (en)
Other versions
SE455093B (sv
SE8603135D0 (sv
Inventor
L D Smirnov
T A Voronina
L G Stolyarova
T L Garibova
R A Akhundov
E A Kuznetsova
K M Djumaev
A V Valdman
G M Rudenko
Original Assignee
Nii Farmakol Akad Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nii Farmakol Akad Med filed Critical Nii Farmakol Akad Med
Priority to SE8603135A priority Critical patent/SE455093B/sv
Publication of SE8603135D0 publication Critical patent/SE8603135D0/sv
Priority to CH2923/86A priority patent/CH667648A5/de
Priority to BE0/216961A priority patent/BE905154A/fr
Priority to FR8611224A priority patent/FR2602232B1/fr
Priority to JP61186714A priority patent/JPS6344565A/ja
Publication of SE8603135L publication Critical patent/SE8603135L/sv
Publication of SE455093B publication Critical patent/SE455093B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8603135A 1986-07-16 1986-07-16 N-nikotinoylaminosyror SE455093B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8603135A SE455093B (sv) 1986-07-16 1986-07-16 N-nikotinoylaminosyror
CH2923/86A CH667648A5 (de) 1986-07-16 1986-07-22 N-nikotinoylaminosaeuren.
BE0/216961A BE905154A (fr) 1986-07-16 1986-07-23 Acides n-nicotinoylamines.
FR8611224A FR2602232B1 (fr) 1986-07-16 1986-08-01 Acides n-nicotinoylamines
JP61186714A JPS6344565A (ja) 1986-07-16 1986-08-08 Ｎ−ニコチノイルアミノ酸

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603135A SE455093B (sv) 1986-07-16 1986-07-16 N-nikotinoylaminosyror

Publications (3)

Publication Number Publication Date
SE8603135D0 SE8603135D0 (sv) 1986-07-16
SE8603135L true SE8603135L (sv) 1988-01-17
SE455093B SE455093B (sv) 1988-06-20

Family

ID=20365125

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603135A SE455093B (sv) 1986-07-16 1986-07-16 N-nikotinoylaminosyror

Country Status (5)

Country Link
JP (1) JPS6344565A (sv)
BE (1) BE905154A (sv)
CH (1) CH667648A5 (sv)
FR (1) FR2602232B1 (sv)
SE (1) SE455093B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06113106A (ja) * 1992-09-25 1994-04-22 Ricoh Co Ltd デ−タ読出処理装置
EP1024134A4 (en) * 1997-10-09 2003-05-14 Ono Pharmaceutical Co DERIVATIVES OF AMINOBUTANIC ACID
JP6479522B2 (ja) 2015-03-23 2019-03-06 本田技研工業株式会社 ケーブル連結機構
RU2612253C1 (ru) * 2016-03-23 2017-03-03 Общество с ограниченной ответственностью "ТАВИТА" Способ получения N-(5-гидроксиникотиноил)-L-глутаминовой кислоты

Also Published As

Publication number Publication date
SE455093B (sv) 1988-06-20
FR2602232A1 (fr) 1988-02-05
CH667648A5 (de) 1988-10-31
JPS6344565A (ja) 1988-02-25
FR2602232B1 (fr) 1988-11-10
BE905154A (fr) 1987-01-23
SE8603135D0 (sv) 1986-07-16

Similar Documents

Publication Publication Date Title
GR78945B (sv)
GR3031492T3 (en) 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
HUT40081A (en) Process for preparing 1,4-dihydropyridine-carboxylic acid amides and pharmaceutical compositions comprising the same
PT75460A (en) 2-<2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy>-beta-phenylpropiophenone its acid addition salts process for its preparation and pharmaceutical compositions
SE8603135L (sv) N-nikotinoylaminosyror
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
NO892152L (no) Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
HUT57749A (en) Process for producing pharmaceutical compositions suitable for treating pathological conditions concerning cerebral blood insufficiency and one special active ingredient
FI853229L (fi) Nya benzodiazepiner, foerfarande foer deras framstaellning och deras anvaendning.
ATE27272T1 (de) 1-aroyl-5-oxo-2-pyrrolidinpropanoic-saeure und deren estern.
ATE22009T1 (de) Verwendung von alpha, alphadialkyladamantylethylaminen zur behandlung von masernvirus.
ATE17571T1 (de) Neue aminopropanolderivate von 1-(2hydroxyphenyl)-3-phenylpropanolen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE82016T1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
RU93036929A (ru) Способ очистки препарата гадолиния-153 от европия-152
ES8407031A1 (es) "procedimiento para la preparacion de n-(2-metil--5-cloro-fenil)-n-metoxiacetil-3-amino-1,3-oxazilidin-urea"
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
RU97111543A (ru) Способ лечения неврологических нарушений, связанных с хронической формой врожденной вирусной инфекции

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603135-8

Effective date: 19950210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603135-8

Format of ref document f/p: F